{"meshTags":["Antibodies, Monoclonal, Humanized","Antineoplastic Combined Chemotherapy Protocols","Bevacizumab","Female","Humans","Inflammatory Breast Neoplasms","Trastuzumab"],"meshMinor":["Antibodies, Monoclonal, Humanized","Antineoplastic Combined Chemotherapy Protocols","Bevacizumab","Female","Humans","Inflammatory Breast Neoplasms","Trastuzumab"],"publicationTypes":["Comment","Journal Article"],"title":"Inflammatory HER2-positive breast cancer.","pubmedId":"22377127"}